The Government of Canada is launching a task force to measure the scope of coronavirus infection in Canada and rapidly provide information needed to manage the COVID-19 pandemic and safely get Canadians back to work.
The COVID-19 Immunity Task Force will generate this vital information, drawing on experts from universities and hospitals across Canada and working closely with provincial and territorial public health officials.
Nancy Ross, McGill’s Associate Vice-Principal, Research and Innovation, recently announced the appointment, effective April 1, 2020, of Dr. Carmen Loiselle as Dialogue McGill’s new Principal Investigator.
New research spearheaded by scientists at McGill University reports that exposing chicken embryos, a model of higher vertebrate development, to leachate from crumb rubber used for example in artificial turf infill allowed to assess the toxicity of environmental pollutants contained in such material.
By Tod Hoffman, Lady Davis Institute for Medical Research
The use of incretin-based drugs is not associated with an increased risk of pancreatic cancer in patients with type 2 diabetes, according to a study published in the latest issue of the British Medical Journal (BMJ).
The research was conducted by the Canadian Network for Observational Drug Effect Studies (CNODES), which used the health records of almost 1 million patients with types 2 diabetes.
